Form D · Biotechnology
Yuko Project, LLC
Nashville, TN · CIK 0002082677
Offering snapshot reported Aug 26, 2025 · SEC filing
- Reported sold
- Yet to sell Offering amount: $10M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 26, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $150K (estimated)
- Form D file number
- 021-555845
A finder may not be utilized.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Dan Maddox | None |
Source: Form D, filed Aug 26, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marc Arrighi | Director, Executive, Promoter |
| Dan Maddox | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
530 Church St Ste B1
Nashville, TN, 37219
Nashville, TN, 37219